Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BioCheetah Pte Ltd logo — We use proprietary biomarkers to develop non-invasive immuno...

BioCheetah Pte Ltd

We use proprietary biomarkers to develop non-invasive immunodiagnostic kits for the diagnosis of urological cancers.

Founded 2018 Singapore Singapore 10 employees Biopharma, Biotechnology

General Information

Company Name BioCheetah Pte Ltd
Founded Year 2018
Location Singapore Singapore +1
Employees 10
Industries Biopharma, Biotechnology
Social

Get notified when BioCheetah Pte Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioCheetah Pte Ltd

BioCheetah Pte Ltd is a Singapore-based startup, founded in 2018, specializing in the development of non-invasive immunodiagnostic kits for the diagnosis of urological cancers. The company leverages proprietary biomarkers discovered and developed by its Scientific Founder, Prof. Jean-Paul Thiery, and co-Founder/Chief Executive Officer, Dr. Kian-Chung Lee, at the Agency Science Technology and Research (A*STAR)-Institute of Molecular and Cell Biology (IMCB). BioCheetah's primary focus is on the development and commercialization of protein-based immunodiagnostic applications, with the first diagnostic applications centered around bladder cancer biomarkers and detection antibodies. The products under development by BioCheetah include professional use in-vitro diagnostic ELISA and Point-of-care test (POCT) kits. These kits will feature a novel multiplex urine-based biomarkers panel designed to provide high sensitivity and specificity for the diagnosis and monitoring of bladder cancer. The company is currently conducting several clinical trials locally and with hospitals worldwide to clinically validate its bladder cancer diagnostic products. BioCheetah operates within the Biopharma and Biotechnology industries and is headquartered in Singapore. As of now, there is no publicly disclosed information available regarding the last investment or the investors involved in the most recent funding round for the company.

Taxonomy: biomarker development, immunodiagnostic kits, urological cancers, Bladder cancer, diagnostic products, in-vitro diagnostics, rapid test, POCT, Point-of-care test, ELISA, biomarkers panel, clinical trials, A*STAR spin-off, biomedical technology, Singapore-based startup

No funding data available for BioCheetah Pte Ltd yet.

Get notified when BioCheetah Pte Ltd raises funding

BioCheetah Pte Ltd Alternatives & Competitors

BioCheetah Pte Ltd vs
Micromedic Technologies Ltd.
Micromedic Technologies Ltd. Israel

Micromedic Technologies specializes in the development and commercialization of innovative in vitro...

Post Ipo Equity
1 employees
Health Care
BioCheetah Pte Ltd vs
Ymir Genomics
Ymir Genomics United States

Ymir Genomics is a biotechnology startup dedicated to finding biomarkers for diagnostics and therape...

1 employees
Biotechnology, Health and Wellness
BioCheetah Pte Ltd vs
E&S Healthcare Co., Ltd.
E&S Healthcare Co., Ltd. Korea South

For The New Hope

Series B
8 employees
Health Care

FAQ About BioCheetah Pte Ltd

We use proprietary biomarkers to develop non-invasive immunodiagnostic kits for the diagnosis of urological cancers.
BioCheetah Pte Ltd was founded in 2018.
BioCheetah Pte Ltd is headquartered in Singapore.
BioCheetah Pte Ltd operates in the following industries: Biopharma, Biotechnology.
BioCheetah Pte Ltd has approximately 10 employees.
Top alternatives and competitors to BioCheetah Pte Ltd include Micromedic Technologies Ltd., Ymir Genomics, E&S Healthcare Co., Ltd., BIOUNIVERSA s.r.l., Nuclea Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioCheetah Pte Ltd and Micromedic Technologies Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioCheetah Pte Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes